AnkurVarmaMD
Oncology • Little Rock, ARHematologic Oncology
Associate Professor Department of Internal Medicine, Division of Hematology, Oncology. Stem Cell Transplantation and Cellular Therapy University of Arkansas for Medical Sciences
Dr. Varma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4301 W Markham St
Little Rock, AR 72205Phone+1 501-686-8530- Is this information wrong?
Summary
- He is an ABIM Board-certified hematologist and oncologist. His areas of expertise are Bone Marrow transplantation with a special focus on alternate donor transplants, Chimeric antigen receptor (CAR) T-cell therapy, and Hematological malignancies.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Blood & Bone Marrow Transplant, 2018 - 2019
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2015 - 2018
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2012 - 2015
RG Kar Medical College CalcuttaClass of 2009
Certifications & Licensure
IL State Medical License 2019 - 2026
AR State Medical License 2023 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsImmune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity.Tyler Fugere, Alan Baltz, Akash Mukherjee, Mamatha Gaddam, Ankur Varma, Muthu Veeraputhiran, Cesar Giancarlo Gentille Sanchez> ;Cancers. 2023 Oct 26
- Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.Vedavyas Gannamani, Ankur Varma, Sunita Nathan, Celalettin Ustun> ;Transplant Immunology. 2023 Feb 1
- 1 citationsMyeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant.Anmol Baranwal, John Byun, Ethan Ritz, Anu Kadanagowd, Danielle Murphy, Debra A Marinovic, Dian Wang, Tochukwu Okwuosa, Deborah Katz, Ankur Varma, Sunita Nathan, Celal...> ;Bone Marrow Transplantation. 2022 Oct 1
- Join now to see all
Hospital Affiliations
UAMS Medical CenterLittle Rock, Arkansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
